Bharat Biotech’s Covaxin is 77.8 per cent effective in protecting against COVID-19 according to results of Phase III trial data approved by the DCGI’s Subject Expert Committee, source said this afternoon.
“Focus On Demand, Supply Kept Inflation Under Control: KV Subramanian<!– –> India is one of the few major economies that has shown four consecutive quarters...
Amid Omicron Scare, Fines And Bans For Unvaccinated In These Countries<!– –> Several countries have taken measures against unvaccinated deployed by governments around the world. In...
Chennai Arrivals: Tests For Rs 3,400, Results In 30 Minutes<!– –> 88 passengers were tested this morning. Chennai: Long wait time at airports for COVID-19...